Teresa Carvalho, MS,  science writer—

The U.S. Food and Drug Administration (FDA) has authorized EpiEndo Pharmaceuticals to conduct a Phase 2a clinical trial of its antibiotic treatment EP395 in people with chronic obstructive pulmonary disease (COPD). It will be the first test of the experimental therapy in COPD patients. The clinical trial…

Strados Labs has been awarded a $990,118 grant to advance the development of its RESP Smart Sensor Platform, a noninvasive wearable lung device to help in the early detection of chronic obstructive pulmonary disease (COPD) and other respiratory infectious conditions. The funds are part of a second phase…

A new algorithm-based approach was developed to identify patients at risk of being misdiagnosed with chronic obstructive pulmonary disease (COPD). Researchers believe this may become an important tool to help healthcare providers in diagnosing several diseases. “Our new algorithm can find the patients who have such an unusual disease…

A new, noninvasive breath biopsy panel — dubbed “a Breathalyzer for disease” — can distinguish several airway disorders, including chronic obstructive pulmonary disease (COPD), its developer said. Launched by Owlstone Medical, the panel may help in diagnosing COPD. The tool, officially called the Respiratory Diseases Research Use Only (RUO)…

A pilot study on the first wireless nebulizer for use by people with chronic obstructive pulmonary disease (COPD) has been cleared by a review board of the U.S. Food and Drug Administration (FDA), Wellinks, the nebulizer’s developer, announced. “Getting into the field with our first digital health offering…

Royal Philips has launched a non-invasive ventilator, BiPAP A40 EFL, to remotely monitor patients with chronic obstructive pulmonary disease (COPD) and help them to breathe easier. The device is already available in some European countries, and its expansion to the rest of Europe is expected in the next…

Training in the handling of inhaler devices improved treatment and eased clinical symptoms in older people with chronic obstructive pulmonary disease (COPD), a study found. COPD patients with evidence of cognitive decline also benefitted from the eight-day training course. The study, “Training improves the handling of inhaler devices…

The use of face masks does not cause intoxication induced by exhaled carbon dioxide (CO2), even in people with lung function impairment such as those with chronic obstructive pulmonary disease (COPD), a study reports. The study, “Effect of Face Masks on Gas Exchange in Healthy Persons and Patients…

The COPD Foundation has launched the COPD360Net project to facilitate, assess, and accelerate clinical trials to further the development and approval of novel digital health tools and treatments for chronic obstructive pulmonary disease (COPD). The project is being launched before November, which is COPD Awareness Month,…

Nebulized ensifentrine (RPL554) — which works both to widen the airways and as an anti-inflammatory — showed a significant early effect on breathlessness in people with chronic obstructive pulmonary disease (COPD), according to the therapy’s developer, Verona Pharma. Apart from easing breathlessness, in four weeks of treatment…